Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Telix and RefleXion Expand Partnership for Prostate Cancer Treatment 2022-06-10 19:00
Keymed Biosciences Announces Dosing of First Patient in Phase I Trial of Bispecific Antibody CM350 2022-06-10 18:42
J INTS BIO successfully held two Korean Advisory Board Meetings for its Novel Oral 4th Generation EGFR TKI (JIN-A02) 2022-06-10 17:00
RAD adds brain tumor technology to portfolio 2022-06-10 10:21
Inteleos Announces Maya Health Alliance as MissionPOCUS Selection for 2022 2022-06-09 22:09
BIORCHESTRA, presenting lead candidate BMD-001 for Alzheimer's disease and drug delivery system technology at the 2022 BIO International Convention 2022-06-09 20:30
Health Canal Appoints New Formal Owner In Efforts To Become Global Leader In Medical Health News 2022-06-09 15:40
Standigm Signs MOU with Merck Korea for AI drug Discovery Research 2022-06-09 14:46
Amaroq Therapeutics hits early milestones and makes key appointments to Scientific Advisory Board 2022-06-09 00:05
OnCusp Therapeutics and Multitude Therapeutics Enter into an Ex-China Licensing Agreement for a Potentially Highly Differentiated CDH6-Targeting Antibody Drug Conjugate 2022-06-08 20:00
Harbour BioMed Announces IND Approval for B7H4x4-1BB Bispecific Antibody 2022-06-08 18:11
Waterdrop Inc. to Report First Quarter 2022 Financial Results on June 15, 2022 2022-06-08 17:11
ASCO 2022 | Ascentage Pharma Releases Updated Data Demonstrating Lisaftoclax's (APG-2575) Therapeutic Potential in Patients with R/R CLL/SLL 2022-06-08 08:00
ASCO 2022 | Ascentage Pharma Releases for the First Time Results of its FAK/ALK/ROS1 inhibitor APG-2449 Demonstrating Safety and Efficacy in Patients with Advanced NSCLC 2022-06-08 08:00
Snap Fitness Announces "Earn Your Apple Watch" Program 2022-06-08 06:00
The 3rd BIO International Convention 2022 is Approaching 2022-06-07 19:23
PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES TO EXPANSION STAGE IN BREAST CANCER BRAIN METASTASES COHORT 2022-06-07 19:00
Chordia Therapeutics Announces Interim Results of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2022 ASCO Annual Meeting 2022-06-07 14:00
ASCO 2022 | Ascentage Pharma Releases Updated Results Demonstrating the Therapeutic Potential of Alrizomadlin (APG-115) plus Pembrolizumab in Patients with Solid Tumors who Progressed on Immunotherapies 2022-06-07 11:30
ASCO 2022 | The First Dataset of Olverembatinib (HQP1351) in Patients with GIST Demonstrates Therapeutic Potential with a Clinical Benefit Rate of 83.3% 2022-06-07 11:28
1 153 154 155 156 157 811